Status:
COMPLETED
To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions
Lead Sponsor:
Sandoz
Conditions:
Healthy
Eligibility:
All Genders
18-59 years
Phase:
PHASE1
Brief Summary
To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.
Eligibility Criteria
Inclusion
- No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.
Exclusion
- Positive test results for HIV or hepatitis B or C.
- Treatment for drug or alcohol dependence.
Key Trial Info
Start Date :
May 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2002
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00881179
Start Date
May 1 2002
End Date
June 1 2002
Last Update
March 28 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.